Advanced search×

Long-term follow-up of laminin alpha2 (merosin)-deficient muscular dystrophy in a cat.

J Feline Med Surg 10(3):274-9 (2008) PMID 18243745

Progressive muscle weakness beginning at 6 months of age was observed in a male Persian-mix cat. Muscle atrophy and joint contracture progressed over the next 3 years. The cat had developed gait difficulty at 8 months of age. The cat died at age of 5 years and 3 months due to an acute respiratory disorder. The clinical, laboratory, necropsy and histopathological findings of the cat were consistent with those of muscular dystrophy. The cat was diagnosed as having laminin alpha2 (merosin)-deficient muscular dystrophy on the basis of immunohistochemical findings. The cat was born in an inbred colony, and another related cat exhibited similar clinical signs. Few cases of laminin alpha2-deficient muscular dystrophy have been reported in cats, and this report provides additional information about the disease.

Version: za2963e q8za9 q8zb9 q8zce q8zd9 q8ze0 q8zfb q8zgd

Similar articles you may find interesting…

  1. [Allergen immunotherapy for allergic rhinitis.]

    Rhinology 51(2):99-110 (2013) PMID 23671890

    Allergic rhinitis, a risk factor for bronchial asthma, is a global health problem that impairs patients` physical and social activity and consequently their quality of life. Specific Immunotherapy (SIT) involves the administration, subcutaneously or sublin- gually, of increasing dose...
  2. Root caries: a periodontal perspective.

    J Periodontal Res (2013) PMID 23647556

    Although there is extensive literature on root caries, consensus is lacking regarding certain aspects, such as diagnostic criteria, prevalence within populations and indisputable risk factors. Advancing age could be an aggravating factor in susceptibility to root caries for the periodontal patient;...
  3. Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C) Study: background, rationale, and study protocol.

    Transplantation Research 2(1):7 (2013) PMID 23641902

    BACKGROUND: Kidney transplantation is the best treatment for patients with end-stage renal failure, but uncertainty remains about the best immunosuppression strategy. Long-term graft survival has not improved substantially, and one possible explanation is calcineurin inhibitor (CNI)...